We're proud to showcase our registry supporting partners
.png){kind=logo}
DataBiologics is an independent real-world evidence platform and outcomes registry. Industry supporters power a international outcomes infrastructure that translates real-world patient data into revenue-ready sales intelligence. All registry data is collected and governed independently, with no sponsor influence.
Powering MLS Laser Adoption With Multi-Center Outcomes Data
Cutting Edge Laser Technologies uses DataBiologics data to power provider consults, sales conversations, and marketing with real-world evidence. Multi-center dashboards show measurable reductions in pain and improvements in function for MLS Laser Therapy — both as a standalone treatment and when combined with orthobiologics.
These visuals are embedded into specialty-specific web pages, sales collateral, webinars, and conference education, helping CE Lasers ethically demonstrate efficacy, shorten sales cycles, and drive adoption across regenerative medicine, pain, and podiatry practices.
Accelerating Adoption of a New Percutaneous Tenotomy Product
As a newer entrant in the percutaneous tenotomy market, TendoNova leverages existing clean, de-identified data from the DataBiologics registry to rapidly generate real-world evidence without waiting years for prospective trials.
By accessing outcomes already captured across tendinosis indications TendoNova can evaluate pain and functional improvement, support early peer-reviewed publications, and benchmark performance within the broader tenotomy category. This approach helps TendoNova demonstrate efficacy sooner, answer clinician questions in the field, and accelerate product adoption with data grounded in real-world clinical practice.
Driving Research, Policy, and Adoption With Outcomes Data
Thanks to the DataBiologics platform, both patients and healthcare professionals will be able to play an active and positive role in objectively demonstrating the impact of Arthrosamid®.
CEO of Contura Orthopaedics, Rakesh Tailor, says; “Patient and clinician feedback is absolutely vital to us as ‘healthcare innovators and pioneers’. We’ve always been committed to collecting and evaluating data in the most effective way possible – ensuring that we, at Contura Orthopaedics, can utilise and analyse data to inform important research papers and presentations, which we hope will help to influence future policy and funding decisions.
Advancing Shockwave Therapy With Shared, Real-World Outcomes Data
SoftWave Tissue Regeneration Technologies uses DataBiologics to aggregate real-world shockwave therapy outcomes across a growing network of contributing clinics. Multi-center dashboards surface trends in pain reduction and functional improvement, allowing SoftWave to support provider education, conference presentations, and peer-to-peer credibility with real patient data. These insights have already been used in high-visibility settings, including elite sports medicine presentations, helping SoftWave demonstrate clinical impact.
“This collaboration empowers clinics to elevate their practices through evidence-based insights, reaffirming our commitment to improving lives with innovative, non-invasive, broad-focused technology,” says John Warlick, Founder of SoftWave.
Scaling PRP Adoption Through Real-World Outcomes Data
EmCyte integrates DataBiologics directly into its provider app, allowing physicians to create accounts, log in, and begin enrolling PRP patients in seconds from their phone or iPad. Through a custom EmCyte-sponsored signup and login flow, new clinics are seamlessly onboarded into the DataBiologics platform as part of EmCyte’s education, ordering, and training ecosystem.
With more than 7,000 PRP cases already captured using EmCyte products, the company is also leveraging de-identified registry data to support marketing and scientific strategy.
